- Headquarters
- Sydney
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- baymatob.com
- Total Funding
- $14.3M
- Last Round
- $6.5M Series AMay 2026
- Rounds
- 5
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 1 investor for this company. The full record is or through the API.
About
Baymatob develops Oli, a wireless wearable maternal and fetal monitoring platform powered by AI. Oli captures physiological data via ten biosensors to identify postpartum hemorrhage risk before birth. The device has received FDA Breakthrough Device Designation.
Summary
It lists 1–10 employees. It has raised $14.3M in total across 5 rounds, most recently a $6.5M Series A round in May 2026. Investors include Scale Investors.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2026
Sign up to see all 5 events
Funding: Grant through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Healthcare AI platform that converts patient-clinician conversations into structured clinical not...

OpenEvidence is an AI copilot for doctors that helps them make high stakes decisions at the point...

Clinical-stage medical technology company developing neural-engineering implants and platforms to...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/baymatob"><img src="https://indexed.vc/api/badge/company/baymatob" alt="Baymatob on Indexed.vc" width="260" height="76" /></a>

